Glenmark shares in focus after recall of 15 lakh bottles of ADHD drug in US
The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark ...
money.rediff2d
Glenmark Recalls ADHD Medication in US: USFDA
Glenmark Pharmaceuticals is recalling 15 lakh bottles of Atomoxetine Capsules in the US due to an N-Nitroso Atomoxetine ...
15 Lakh Bottles Of ADHD Medication Recalled In U.S. By Glenmark
According to the U.S. health agency, Glenmark Pharmaceuticals is recalling over 15 lakh bottles of a generic drug used to ...
Daily23h
Glenmark US arm recalls 15 lakh bottles of ADHD medication in US
Glenmark Pharmaceuticals Inc, USA, an arm of the Mumbai-based Glenmark Pharmaceuticals, is recalling around 14.76 lakh ...
Glenmark recalls 15 lakh bottles of ADHD medication in U.S.: USFDA
Glenmark Pharmaceuticals recalls 14.76 lakh bottles of Atomoxetine Capsules in the US due to impurity concerns.
The Financial Express2d
Glenmark recalls 15 lakh bottles of ADHD medication due to ‘CGMP Deviations’ in United States
ADHD is a neurodevelopmental disorder that affects a person's ability to focus, control impulses, and regulate their activity ...
Medscape2d
Atomoxetine: The First Nonstimulant for the Management of Attention-Deficit/Hyperactivity Disorder
Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...
Glenmark recalls 15 lakh bottles of attention deficit hyperactivity disorder medication in US
Glenmark Pharmaceuticals Inc, USA, a subsidiary of the Mumbai-based drug maker, is recalling around 14.76 lakh bottles of ...
Stocks to watch, Mar 3: Auto stocks, Coal India, Hindustan Zinc, ACME Solar
Glenmark Pharma is recalling close to 15 lakh bottles of a generic medication used in treating attention deficit ...
The Tribune1d
Glenmark recalls 15 lakh bottles of attention deficit hyperactivity disorder medication in US
Glenmark Pharmaceuticals Inc, USA, a subsidiary of the Mumbai-based drug maker, is recalling around 14.76 lakh bottles of Atomoxetine Capsules in multiple strengths The Tribune, now published from ...